Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Autologous Cell Therapy Market Growth in 2025?
The market size for autologous cell therapy has seen a swift expansion in the past few years. The market forecasts predicts a growth from $10.28 billion in 2024 to $12.19 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 18.6%. The past growth in this sector has largely been driven by progress in regenerative medicine, rising instances of chronic diseases, enriched insights into cellular biology, patient inclination towards personalized medicine, and the success and positive results achieved clinically.
What Is the Forecast for the Autologous Cell Therapy Market Size Through 2029?
The market size of autologous cell therapy is projected to witness robust expansion in the coming years. The market is anticipated to reach a value of “$23.33 billion by 2029, progressing at a compound annual growth rate (CAGR) of 17.6%. This growth over the projected period can be credited to the constant advancement in regenerative medicine, broadening use in various medical specialties, improvements in cell culture methodologies, escalated investment and research activities, supportive regulation, and standardization. Key market trends for the forecast period consist of the advent of automated production technologies, incorporation of biomarkers in treatment methods, the rise of point-of-care cell processing, extension beyond hematopoietic stem cells, and industry collaborations and partnerships.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10771&type=smp
What are the Key Market Players in Autologous Cell Therapy Market and How They’re Evolving?
Major companies operating in the autologous cell therapy market include Bristol-Myers Squibb Company, Novartis AG, Vericel Corporation, Holostem Terapie Avanzate S.r.l., Pharmicell Co. Ltd., Opexa Therapeutics Inc., Tego Science AB, Brainstorm Cell Therapeutics Inc., Caladrius Biosciences Inc., Lineage Cell Therapeutics Inc., Castle Creek Biosciences Inc., Gilead Sciences Inc., Johnson & Johnson, CORESTEM Inc., Dendreon Pharmaceuticals LLC, Medipost Co. Ltd., PharmaJet Inc., Bioject Medical Technologies Inc., Medical International Technology Inc., INJEX Pharma AG, Lonza Group Ltd., Corning Incorporated, Takeda Pharmaceutical Company Limited, CSL Limited, AstraZeneca plc, Moderna Inc., Sinovac Biotech Ltd., Valneva SE, Bavarian Nordic A/S, Dynavax Technologies Corporation
What Are the Primary Growth Drivers in the Autologous Cell Therapy Market?
The proliferation of chronic diseases is anticipated to fuel the expansion of the autologous cell therapy market. Chronic illnesses are defined as diseases or conditions that persist for over a year and necessitate continuous medical care. Autologous cell therapy is a hopeful method for the treatment and management of these illnesses, utilizing the patient’s own cells, which are grown and expanded outside the body before being re-implanted into the donor. For example, figures from the National Library of Medicine in the US, indicate that by 2050, the number of Americans over the age of 50 with at least one chronic illness is projected to rise to 142.66 million, as recorded in January 2023. Therefore, the elevated incidence of chronic diseases is propelling the autologous cell therapy market’s development.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10771&type=smp
What Are the Leading Segments in the Global Autologous Cell Therapy Industry?
The autologous cell therapy market covered in this report is segmented –
1) By Therapy: Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies
2) By Source: Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources
3) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications
4) By End User: Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users
Subsegments:
1) By Autologous Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Adipose-Derived Stem Cell Therapy
2) By Autologous Cellular Immunotherapies: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell Therapy
What Are the Key Market Trends in the Autologous Cell Therapy Industry?
The rise in technological advancement is becoming a dominant trend in the autologous cell therapy market. Key market players are adopting automation in the autologous cell therapy procedure to enhance efficiency and stay competitive within the industry. As an example, Lonza, a Switzerland-based company serving the pharmaceutical, biotechnology, and nutrition industries, rolled out the Cocoon Platform in April 2022. This novel technology is designed for the manufacturing of personalized cell and gene therapies. The use of an automated closed system by the Cocoon Platform reduces contamination risk and ensures a sterile manufacturing process. This subsequently improves quality, decreases labor and material expenses, and paves the way for efficient scale-up of autologous T-cell products.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report
What Is the Regional Outlook for the Autologous Cell Therapy Market?
North America was the largest region in the autologous cell therapy market in 2024.Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10771
This Report Delivers Insight On:
1. How big is the autologous cell therapy market, and how is it changing globally?
2. Who are the major companies in the autologous cell therapy market, and how are they performing?
3. What are the key opportunities and risks in the autologous cell therapy market right now?
4. Which products or customer segments are growing the most in the autologous cell therapy market?
5. What factors are helping or slowing down the growth of the autologous cell therapy market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
